Join Now

Yearly Archives: 2025

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

By Natalie Themm | Published December 11, 2025

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12).

Posted in BioUtah News | Tagged | Comments Off on Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

By Natalie Themm | Published December 11, 2025

New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement.

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®

By Natalie Themm | Published December 11, 2025

FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8.

Posted in BioUtah News | Tagged | Comments Off on CLENE ANNOUNCES STATISTICALLY SIGNIFICANT ALS BIOMARKER RESULTS SUPPORTING ACCELERATED APPROVAL PATHWAY FOR CNM-AU8®

Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation

By Natalie Themm | Published December 11, 2025

Prestigious recognition validates Canary Speech’s leadership in healthcare-focused AI voice technology and its proven interoperability with the Microsoft Cloud

Posted in BioUtah News | Tagged | Comments Off on Canary Speech Earns Microsoft Solutions Partner: Healthcare AI Certified Software Designation

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

By Natalie Themm | Published December 4, 2025

bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

Posted in BioUtah News | Tagged | Comments Off on bioMérieux Celebrates New Regional Headquarters in Riyadh, Saudi Arabia

PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

By Natalie Themm | Published December 4, 2025

PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possible

Posted in BioUtah News | Tagged | Comments Off on PolarityBio Completes Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

By Natalie Themm | Published December 4, 2025

Milestone enables immediate production of SiN/PEEK custom devices

Posted in BioUtah News | Tagged | Comments Off on SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

5 Trends to Expect From Vocal Biomarker Technology in 2026

By Natalie Themm | Published December 4, 2025

By Henry O’Connell, CEO and co-founder of Canary Speech   Vocal biomarker data has come a long way in a short amount of time. No longer relegated to the pages of science fiction, the power of the human voice to assist in diagnoses is established fact. Providers already possess technological platforms that make informed care […]

Posted in BioUtah News | Tagged | Comments Off on 5 Trends to Expect From Vocal Biomarker Technology in 2026

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

By admin | Published November 20, 2025

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]

Posted in BioUtah News | Comments Off on Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

By admin | Published November 20, 2025

This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]

Posted in BioUtah News | Comments Off on Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services

By admin | Published November 20, 2025

SALT LAKE CITY, November 19, 2025— With a deadline approaching on January 31, 2026, ARUP Laboratories has joined other clinical laboratories in advocating for passage of the federal Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, which would block looming cuts in payments for lab testing services, relieve labs of burdensome reporting, […]

Posted in Policy News | Comments Off on ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services

Recap: 2025 Mayer Brown Utah Life Sciences Summit

By admin | Published November 14, 2025

The 2025 BioUtah Utah Life Sciences Summit (ULSS) took place November 12 at the Hilton Salt Lake City Center, featuring keynote speakers, awards, educational sessions, networking opportunities, and the signing of a Memorandum of Understanding (MOU) with the Korea Health Industry Development Institute. With 650 registrants, this year’s Summit was the biggest yet. Jefferson Moss, […]

Posted in Policy News | Comments Off on Recap: 2025 Mayer Brown Utah Life Sciences Summit

A Special Thanks To Our Legacy and Platinum Elite Members